The purpose of present study was to evaluate whether the ERCC1 mRNA expression levels could predict the treatment response of patients with locally advanced cervical squamous cell carcinoma (LACSCC) who underwent CCCRT. The gene discussed is ERCC1; the disease is cervical squamous cell carcinoma.